Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients
Clinical trial NCT02137889 · TERMINATED
Trial details
- NCT number
- NCT02137889
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2012-11-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.